U.S. Marine and Shipping Stock News

Erie Indemnity (ERIE) closed out FY 2025 with fourth quarter revenue of US$951.0 million and basic EPS of US$1.21, while trailing twelve month revenue stood at about US$4.1 billion and EPS at US$10.70. Together, these figures set the scene for a year in which margins and earnings quality will be front of mind for investors. The company has seen quarterly revenue move from US$924.1 million and EPS of US$3.29 in Q4 2024 to US$951.0 million and EPS of US$1.21 in Q4 2025. Those shifts, alongside...

If you are trying to figure out whether RXO is attractively priced right now, it helps to separate the share price story from the underlying valuation story. RXO closed at US$14.84 recently, with a small 0.1% move over the last week, a 4.6% decline over the past month, a 15.6% gain year to date, and a 25.5% decline over the past year. Recent price moves have put RXO back on the radar as investors reassess transportation and logistics names in light of sector specific news flow and changing...

Avidity Biosciences (RNA) has wrapped up FY 2025 with fourth quarter revenue of about US$0.9 million, a basic EPS loss of US$1.54 and a net loss of roughly US$237.1 million. Over recent quarters the company has seen revenue move from US$2.3 million in Q3 2024 to US$12.5 million in Q3 2025. Basic EPS shifted from a loss of US$0.65 in Q3 2024 to a loss of US$1.27 in Q3 2025, and trailing 12 month EPS landed at a loss of US$4.97. This sets the stage for a results season where investors are...

Targa Resources (NYSE:TRGP) announced a major build out of natural gas processing plants in the Permian Basin. The company is adding a new large scale NGL fractionator, Train 13, at its Mont Belvieu complex. Targa outlined additional growth projects, including carbon capture initiatives and AI driven technology upgrades across its system. The expansion is described as aimed at meeting rising energy demand tied to data centers and broader market needs. Targa Resources, a large midstream...

Cogent Biosciences (NasdaqGS:COGT) has advanced its lead therapy bezuclastinib into a Phase 3 trial for systemic mastocytosis. The company has also filed a significant shelf registration that could be used to raise capital in the future. These updates highlight progress in Cogent Biosciences' clinical pipeline alongside preparations for potential funding needs. Cogent Biosciences enters this news cycle with its shares at $39.18 and very large 1 year returns, reflecting strong recent...

Great Lakes Dredge & Dock (GLDD) capped FY 2025 with Q4 revenue of US$256.5 million and basic EPS of US$0.19, rounding out a trailing twelve month picture that includes total revenue of US$888.3 million and EPS of US$1.10. Over the past few quarters, the company has seen revenue move from US$191.2 million in Q3 2024 to US$202.8 million in Q4 2024, then to US$242.9 million in Q1 2025 and US$195.2 million in Q3 2025, with quarterly EPS ranging from US$0.13 to US$0.50 over the same stretch. This...

China Yuchai International (NYSE:CYD) has just posted its FY 2025 first half numbers, with revenue of C¥13.8b and basic EPS of C¥9.75, setting the tone for a year in which investors are closely tracking how earnings and sales are holding up. The company has seen revenue move from C¥10.3b in the first half of 2024 to C¥13.8b in the first half of 2025, while basic EPS went from C¥5.88 to C¥9.75 over the same period. With trailing 12 month EPS at C¥14.32 on revenue of C¥24.7b, the results put...

Expand Energy has partnered with Evolution Well Services to deploy 100% electric hydraulic fracturing technology in Northeast Appalachia. The initiative targets lower noise, a smaller equipment footprint, reduced surface disruption, and real time environmental monitoring. The move reflects a focus on operational efficiency and environmental performance that has not featured in recent company updates. For investors watching Expand Energy (NasdaqGS:EXE), this partnership adds a fresh...

Clearway Energy (CWEN.A) just closed out FY 2025 with Q4 revenue of US$310 million and a basic EPS loss of US$0.85, capping a trailing twelve month period that totaled US$1.4 billion of revenue and US$1.42 in basic EPS. The company has seen quarterly revenue move from US$256 million in Q4 2024 to US$310 million in Q4 2025. Over the same period, basic EPS shifted from US$0.03 to a loss of US$0.85, against a backdrop of trailing twelve month net income of US$169 million. For investors, that mix...

THOR Industries (NYSE:THO) has reorganized its North American RV operations to create two new operating groups focused on alignment and efficiency. The company announced related executive leadership changes as part of this restructuring. The move is intended to reshape how THOR coordinates its brands and manages its RV segment across North America. THOR Industries, a major manufacturer in the recreational vehicle space, sits at the center of a sector that is closely tied to consumer...

If you are wondering whether EVERTEC's current share price still reflects its true potential, or if the market has marked it down too far, this article is for you. With EVERTEC's share price at US$25.78 and share price returns of a 2.2% decline over 7 days, 13.5% decline over 30 days, 10.1% decline year to date, 21.4% decline over 1 year, 29.3% decline over 3 years and 28.1% decline over 5 years, many investors are asking what the stock is really worth now. Recent coverage has focused on...

What recent returns say about QMMM Holdings (QMMM) QMMM Holdings (QMMM) has attracted attention after a 19.4% one day move, a return of 19.4% over the past 3 months, and a year to date gain of 87.44%. See our latest analysis for QMMM Holdings. That surge in the 1 day share price return and the latest share price of $119.4 comes on top of a 90 day share price return of 19.4% and a very large year to date share price gain. The 1 year total shareholder return is also very large, suggesting...

Why Gossamer Bio’s PROSERA readout matters now Gossamer Bio (GOSS) has drawn fresh attention after releasing topline Phase 3 PROSERA data for seralutinib in pulmonary arterial hypertension and scheduling a special call to review the results and potential next steps with regulators. See our latest analysis for Gossamer Bio. The unveiling of the PROSERA Phase 3 topline data and the planned FDA discussions come after a sharp reset in sentiment, with a 30 day share price return of 84.32% decline...

MFA Financial (MFA) is on investor watch after posting annual revenue of US$325.4 million and net income of US$135.7 million, with recent returns mixed over the day, week, month and past 3 months. See our latest analysis for MFA Financial. At a share price of US$9.90, MFA Financial has seen short term share price softness alongside a positive 3 month share price return and a stronger 1 year total shareholder return of 11.27%. This suggests that recent price swings are occurring within a more...

If you are wondering whether OFG Bancorp at around US$41.39 is still good value or already pricing in a lot of optimism, you are asking the right question. The stock has had mixed recent returns, with a 1.2% decline over the last 7 days, an 11.4% gain over 30 days, 0.9% year to date, 2.4% over 1 year, 50.3% over 3 years and 134.3% over 5 years, which can change how investors think about both upside and risk. Recent news around OFG Bancorp has focused on its position as a US regional bank and...

Ategrity Specialty Insurance Company Holdings (ASIC) has drawn fresh attention after a sharp recent move in its share price, with the stock up 6.1% over the past day and 32.7% in the past week. See our latest analysis for Ategrity Specialty Insurance Company Holdings. The recent surge in Ategrity Specialty Insurance Company Holdings’ share price, including a 32.7% 7 day share price return and a 23.97% 90 day share price return, suggests short term momentum is building while year to date...

Kinetik Holdings (NYSE:KNTK) is reported to be exploring a potential sale process. Western Midstream Partners has shown interest in a possible acquisition of Kinetik Holdings. The situation points to possible changes in ownership structure and future direction for the company. Kinetik Holdings, listed on the NYSE under ticker KNTK, operates in the midstream energy space, connecting upstream production with downstream demand through gathering, processing, and related services. Attention on...

Crinetics Pharmaceuticals (NasdaqGS:CRNX) reported positive clinical trial results for its congenital adrenal hyperplasia treatment. The company also announced positive initial sales for its oral therapy for acromegaly, alongside progress on related regulatory milestones. These updates highlight recent clinical and commercial developments in Crinetics' rare endocrine disease portfolio. Crinetics Pharmaceuticals focuses on therapies for rare endocrine conditions, an area where treatment...

CarGurus, NasdaqGS:CARG, has authorized a new $250 million share repurchase program. The company is sharpening its focus on its core marketplace and international growth after winding down CarOffer. Management highlighted strong revenue, record retention, and faster dealer acquisition, including outside the US. CarGurus, trading at $27.86, sits at an interesting crossroads, with a 3-year return of 63.4% and a 5-year return of 5.5%. In the shorter term, the stock is down 18.1% over the past...

Wondering if Wynn Resorts at around US$107 is offering value today or if the easy money has already been made? This article is designed to help you frame that question clearly. The stock is down about 5.4% over the last week and 5.5% over the last month, yet it still shows a 20.1% return over the past year. That combination can change how you think about both upside potential and risk. Recent coverage has focused on Wynn Resorts as a major casino and resort operator with exposure to both...

Earlier in February 2026, Bank of Hawaii Corporation disclosed that Director Robert W. Wo Jr., through the Robert Ching Wo Trust 1985, sold 5,000 indirectly held common shares, while the bank also confirmed its CEO plans to retire at the end of March 2026. The combination of leadership transition and insider share sale has sharpened investor focus on how Bank of Hawaii will manage succession and governance continuity. We’ll now examine how the CEO’s planned retirement may influence Bank of...

Stepan (SCL) has wrapped up FY 2025 with fourth quarter revenue of US$553.9 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of about US$2.3 billion and EPS of US$2.05. Over recent periods, revenue has moved from US$546.8 million in Q3 2024 to the US$590.3 million to US$594.7 million range across the first three quarters of 2025, with quarterly EPS ranging from US$0.47 to US$0.86, and trailing EPS shifting between US$2.01 and US$2.54. With a trailing net...

In February 2026, Forum Energy Technologies reported that Q4 2025 sales were US$202.2 million with net income of US$2.07 million, while completing a US$35.00 million buyback of 1.40 million shares, or 11.68% of its stock, under the repurchase plan announced in December 2024. The company exited 2025 with a US$312.0 million order backlog, the largest in 11 years, and issued 2026 guidance calling for US$800.0–US$880.0 million in revenue, highlighting how improved earnings, a stronger order...

CubeSmart (NYSE:CUBE) has entered a $250 million joint venture with CBRE Investment Management. The partnership is focused on expanding CubeSmart's presence in high growth self storage markets. The new venture comes as the self storage market shows signs of recovery and renewed investor interest. For investors watching NYSE:CUBE at a share price of $39.66, this move adds a fresh layer to the story. The stock is up 12.0% year to date and has returned 34.6% over 5 years, while 1 year and 3...